Analyst Reco. Takeda Pharmaceutical Company Limited Mexican S.E.

Equities

TAK N

US8740602052

End-of-day quote Mexican S.E. Other stock markets 18:00:00 2024-06-19 EDT			5-day change	1st Jan Change
231.5 ^MXN	-3.73%		-3.73%	-3.42%

06-24	Hutchmed China notes Takeda obtains EU approval for Fruzaqla	AN
06-24	Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Toyota becomes Asia's most shorted large-cap stock - Hazeltree	03-12	RE
Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy	02-13	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy	23-10-03	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy	23-09-22	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy	23-05-31	MT
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating	23-05-16	MT
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating	23-04-04	MT
BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20	23-03-16	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy	23-03-06	MT
Jefferies Downgrades Takeda Pharmaceutical to Hold From Buy	22-08-01	MT
Cowen Upgrades Takeda Pharmaceutical to Outperform From Market Perform	22-07-19	MT
TAKEDA PHARMACEUTICAL : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight	21-10-07	MT
Japan Petroleum Exploration : Japanese shares end higher on Wall Street gains, stable U.S. rates	21-05-21	RE
Japanese shares fall on profit booking, checking U.S. rates	21-04-05	RE
Takeda Pharmaceutical : Says Phase 3 Study Results Show Takhzyro Curbed HAE Attack Rate Long Term	20-11-13	MT
Takeda Pharmaceutical Company Limited: Takeda Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year	19-07-31	EQ
Takeda Pharmaceutical : Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year	19-07-31	BU
Takeda Pharmaceutical : Announces Execution of Loan Agreement in Connection with Proposed Acquisition of Shire plc	18-12-03	BU
Takeda Pharmaceutical : Announces Execution of Senior Short Term Loan Facility Agreement and Subordinated Syndicated Loan Agreement and Second Amendment to Bridge Credit Agreement in Connection with Proposed Acquisition of Shire plc	18-10-26	BU
BAYER : Germany's Merck hires JP Morgan to sell consumer health	17-09-08	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Takeda Pharmaceutical Company Limited Mexican S.E.

Equities

TAK N

US8740602052

Analyst Reco.

Filters